The more developed biomarkers become through research, the more clinicians will know about an individual injury — biomechanically in the brain — and then, the better they can develop and offer effective treatments.
See more videos with Dr. Ronald Hayes.
About the author: Ronald Hayes, PhD
Ronald Hayes, PhD is a co-founder and president of Banyan Biomarkers, Inc. He is director of Banyan’s Clinical Programs and Banyan Laboratories.
Produced by Brian King, Vicky Youcha, and Erica Queen, BrainLine.